Related Experiment Video
Updated: May 29, 2026

3D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells
Published on: October 17, 2025
Gut microbial metabolites for potentiating cancer therapy
Stephan Kamrad1, Nicola Gagliani2, Trevor D Lawley3
1The Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, UK.
None:
The gut microbiome exerts distant and local effects on tumours, healthy epithelial cells, and the immune system through the production of bioactive metabolites. This influences cancer therapy responses across treatment modalities and cancer types. In this review, we discuss promising approaches to boost beneficial microbiota-derived metabolites to enhance existing cancer therapies, including prebiotics, probiotics, postbiotics, and live biotherapeutic products. Each approach faces challenges in achieving physiological concentrations and tissue distribution, as well as different regulatory regimes and commercial landscapes. With promising early clinical trials and significant scientific and commercial activity in these areas, there is hope that targeted, metabolite-focused interventions will soon benefit cancer patients.
Related Concept Videos
Drugs that Stabilize Microtubules
Functions of the Gut Microbiota
Drugs that Destabilize Microtubules
Microbiota Modulation by Antibiotics
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
